Welcome to the Archer Pharmaceuticals website! Use this panel to navigate all the pages of the site.
50 Million of people around the world are currently suffering from Alzheimer's disease - 5.5 million of them in the US. Archer Pharmaceuticals was formed in 2008 to advance drug therapies to slow or prevent the disease.
What's New? See the latest announcements from Archer Pharmaceuticals.
Archer's world-class team of researchers and scientists are, after extensive laboratory-based research, repurposing drugs (previously designed for use in hypertension) for Alzheimer's disease. This approach has been tested in human clinical trials and shows early promise in slowing or preventing the disease.
Alzheimer’s disease is a growing problem around the world, with devastating consequences for patients, caregivers and families. As we understand more and more about the disease, it's clear it can be halted.
Even modest therapeutic advances that delay Alzheimer’s Disease onset and progression could significantly reduce the global burden of the disease and the level of care required by patients. Want more information?